Tag: CSL
CSL boosts AU’s plasma manufacturing capability with new Fractionation Facility
Global biotech company CSL has opened a new $900 million Plasma Fractionation Facility in Victoria, bolstering the future of plasma manufacturing in Australia.
CSL dispatches first Australian made doses of AstraZeneca COVID-19 Vaccine
CSL has announced the first of the Australian made AstraZeneca COVID-19 Vaccine have been dispatched.
In the announcement today, the global biotechnology company cited collaboration...
Government should invest in Australia’s vaccine manufacturing capability – The Greens
In light of recent AstraZeneca approval for use in Australia, the political party reiterated the need to further diversify jab availability in the country.
The...
CSL makes record 45% profit leap, takes on vaccine manufacturing
As demand for vaccines ramps up, the blood products giant has taken on the enormous task of manufacturing COVID-19 jabs – and so far,...
Seqirus to build a world-leading vaccine facility in Tullamarine
Seqirus, a subsidiary of Victorian-based global biopharmaceutical leader CSL, has inked an agreement with the Federal Government to develop a new high-tech vaccine manufacturing...
CSL commences manufacture of University of Oxford /AstraZeneca vaccine candidate
CSL has announced it will commence manufacturing the University of Oxford/AstraZeneca AZD1222 COVID-19 vaccine candidate on Monday 9th November.
The global biotech company has separate...
CSL inks final agreement to manufacture UQ COVID-19 vaccine candidate
CSL‘s subsidiary, Seqirus, has signed a final agreement with the Federal Government for the supply of 51 million doses of the University of Queensland-CSL...
CSL to manufacture and supply two COVID-19 vaccine candidates for Australia
The Australian Government has signed an agreement with CSL under which the global biotech company will supply 51 million doses of the University of...
Queensland begins COVID-19 vaccine human trials
Innovation Minister Kate Jones has announced that human trials will begin today on the University of Queensland’s promising COVID-19 vaccine.
More than 4000 people have...
CSL partners with University of Queensland and CEPI to advance development and manufacture of...
Media Release
CEPI, the Coalition for Epidemic Preparedness Innovations, CSL (ASX:CSL) and The University of Queensland (UQ) today announced that they have entered into a...
Featured Article
The future of sports manufacturing: Inside M2M Group’s AI-powered strategy
As the sports manufacturing industry evolves, artificial intelligence (AI) is emerging as a critical catalyst for innovation and efficiency.
